This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
spk03: Good morning and welcome to Healthstream's first quarter 2024 earnings conference call. At this time, I would like to inform you that this conference is being recorded and that all participants are in a listen-only mode. At the request of the company, we will open the conference up for questions and answers after the presentation. I will now turn the conference over to Molly Condra, Vice President of Investor Relations and Communications. Please go ahead, Ms. Condra.
spk02: Thank you and good morning. Thank you for joining us today to discuss our first quarter 2024 results. Also in the conference call with me today is Robert A. Frist, Jr., CEO and Chairman of HealthStream, and Scotty Roberts, CFO and Senior Vice President of Finance and Accounting. I would also like to remind you that this conference call may contain forward-looking statements regarding future events and the future performance of HealthStream that could involve risk and uncertainties that could cause the actual results to differ materially from those projected in the forward-looking statements. Information concerning these risks and other factors that could cause the results to differ materially from those forward-looking statements are contained in the company's filings with the SEC, including forms 10-K, 10-Q, and our earnings release. Additionally, we may reference measures such as the adjusted EBITDA, which is a non-GAAP financial measure. A table providing supplemental information on adjusted EBITDA And reconciling to net income attributable health stream is included in the earnings release that we issued yesterday and may refer to in this call. So with that start today, I'll turn the call over to CEO Bobby Frist.
spk09: Thank you, Molly. Good morning, everyone, and welcome to our first quarter 2024 earnings call. As our analysts sometimes say, it was a solid print. In the first quarter, we achieved record revenue and record-adjusted EBITDA, In fact, our quarterly financial performance showed year-over-year increases in each of the major categories we highlight in our earnings release. I'm excited to be able to report that type of performance. The first quarter revenues were $72.8 million, up 6% over the first quarter of last year, and adjusted EBITDA was $17.1 million, up 24% over the first quarter of last year. We were able to reiterate our financial guidance ranges for the full year of 2024, And right now, we have the full expectation that we'll be able to hit the ball right down the middle of the fairway. We're looking to the middle of the range in performance. So we're excited to deliver these strong financial results and reiterate our financial ranges with an expectation of going right down the middle. Later in this call, after Scotty's discussion about financials, I'm going to describe some of the developments in learning, credentialing, and scheduling application suites that are helping drive these results. I do want to back up a little bit and talk about an emerging trend we're seeing that I think is worth calling out. The trend I'm referring to is the increasing amount of attention that healthcare organizations are paying to their workforce, kind of broadly defined. Now more than ever, we believe that healthcare CEOs are embracing the fact that their workforce is their most valuable asset. And the staffing shortages that were exacerbated by the pandemic really served to reinforce the ongoing importance of taking care of your workforce And hopefully, from our point of view, investing in them to retain and develop them in their capabilities and capacity. And, you know, these are the things that Healthstream has been focused on for a long, long time. We're just laser focused on workflow applications that improve both the quality, the knowledge of, and the knowledge by these healthcare professionals. And, of course, their skill sets. We also make sure the right people are in the right place at the right time. So a lot of things that we do that help organizations focus and bring deliberate focus on on retaining and developing. In fact, if you ask any health stream employee, you know, I'd say they're proud to say that our vision has always been about improving the quality of health care through the people of health care by improving who they are and what their skills are. And so we've held that vision to improve the quality of health care by developing the people who deliver care for a long time. And based on our conversations with customers, it's just increasingly becoming a top priority for them as well, the healthcare workforce as a topic. And you can look at that from any direction, from workforce shortages, the need to cross-develop competencies and skills. These are all emergingly kind of the hospitals are realizing their need to invest in these areas. Healthcare can be complex, but working together with our customers, we help them take care of these people, and we know how to do that well. It's just something that benefits everyone. So our three application suites, along with the HealthStream platform underpinning them now, and our deep network of customers have helped position HealthStream as the workforce platform of choice, or maybe sometimes we say the people platform for healthcare. Moving on to more specific business topics, I want to share two updates that we believe are emerging parts of our business that could become growth drivers in future years. To be clear, not material contributors today, But the expected growth results are, we're excited to see the initial results in these areas that we're going to discuss. The first is we're excited to advance our commerce capabilities. For the longest time, most all of our sales have been done, facilitated by a field sales organization, which is wonderful. And we build strong bridges and relationships with thousands of customers through this incredible sales organization. But increasingly they're supported with e-commerce capabilities that are a part of our H-Stream platform. And we're building out these capabilities for three areas of commerce. The first is kind of enterprise-level purchasing we call collaborative purchasing. And we brought this up on prior calls, but our collaborative purchasing tools are now evolving with better e-commerce capabilities built in. And so that's exciting. The second is I guess what we would call departmental-level purchasing. It's business-to-business purchasing kind of at the departmental level. And we now have new tools that we're launching that help department heads and others manage their education, training, and development budgets through commerce tools, which is exciting. And then finally, the one I'm going to talk about is actually the newest. Our ability is to focus on the individuals in our ecosystem with direct to individual commerce purchasing. And during our last call, I mentioned to you that we'd started selling a course called the DEA Mandated Opioid Course. It's required a position through kind of a federal mandate, so it has strong tailwinds. But through our e-commerce capabilities and through ,, we were able to present the opportunity to purchase this course in our own network, and in some cases, promoting it inside of our own application areas. I can now report that we had approximately half a million in DEA course sales, direct to professional, direct to doctors, sales of the DEA course during the first quarter alone. And so this is a really an exciting kind of breakthrough moment as we use our new commerce tools to allow for direct purchasing by physicians of, in this case, this course. Now again, this course is a bit anomalous because it's a unique opportunity based on a federal mandate. It's time sensitive and we happen to have just the right content for it. But nonetheless, it wouldn't have been possible without being powered by our new commerce tools. So, taken by itself, this represents, you know, one group of individuals, but in the greater scheme of things, we think it represents an opportunity to expand these direct professional commerce capabilities. You know, and as the people platform of healthcare, I think Healthstream is well-positioned to know what individuals need, when they need which course and when, and then also how to get it to them. And so, I feel well-positioned to extend this commerce capability to be part of the whole platform for healthcare. Well, you know, the other channel where we're seeing expansion of direct commerce is through Nurse Grid Learn. And you'll recall that our Nurse Grid app is extraordinarily popular with nurses. We have over a half a million monthly active users. And if you ask almost any nurse, you're going to have a really high hit rate that they both like Nurse Grid, the app, which helps them manage their personal schedules and work schedules. And they're beginning to appreciate some of its new features and capabilities like Nurse Grid Learn. And so we began to see some recent transactional volume through NurseGrid Learn direct to nurses as well to see that start to be powered by our new commerce tools. Let's move on to the expansion of our total addressable market, which we announced in October of last year. Specifically, I want to provide you with some developments that we're making around nursing schools. After completing our first major enterprise sale to one of the largest nursing schools in the nation, I'm pleased to announce that we have now fully implemented our HealthStream technology platform and the Red Cross resuscitation at over a dozen of their campuses, and we expect a full rollout during this quarter, the second quarter. So an exciting rollout to one of the largest nursing schools in the nation, using the HealthStream technology platform, the HealthStream ID, along with the Red Cross resuscitation suite, and now they're entering work when they get their first job after graduating and becoming nurses. They enter work with a Red Cross certificate thanks to this new relationship with nursing school, with this large nursing system. And so we're excited to see them enter the workforce with that ID and with that Red Cross credential. We'll be able to report more on our progress here financially, but the implementation wave has begun and we're really excited about that. And really the great opportunity is that the data on their completion of that certificate would carry forward with them into work if they land at a facility or health organization that uses our learning application suite. And so we're really excited about that advance, of course, also powered by the H-treme platform and its interoperability APIs. So again, excited to see both technical progress and financial implementation progress in the nursing school market. Of course, with this as a working model, we'll work our best to figure out how to expand sales opportunities in that channel as well. So those are the two opportunities I wanted to cover. The DEA made direct to professional and the nursing school early developments there have been in the nursing market, nursing school market, and nursing student market. And so we're excited to report progress in both of those areas. I do want to manage expectations. These are new areas, new channels. They're not material parts of our business, but we do see some light. We're excited to see some light at the end of the development panel and declaring these as an expanded market opportunity in our prior earnings calls. Again, we're excited to see those developments. I want to describe just as a reminder for anybody new on the call a base level description of our business so you can kind of take away the nature of our business. First and foremost, Healthstream is a healthcare technology company. We're focused on the development of our technology platform, and we're dedicated to developing, credentialing, and scheduling the healthcare workforce. So three kind of unique healthcare workflows related to their people that we provide through our SaaS-based application stacks. And increasingly, those three separate SaaS technology stacks that do credentialing, learning and development, and scheduling are becoming interoperable through the HStream technology platform we've been building. Historically, we sell all of our solutions on a subscription basis under contracts that average three to four years, which makes our revenues both recurring and predictable. And we'd like to get some credit for that eventually, that this is a recurring revenue SaaS subscription business. In fact, 96% of our revenues are subscription-based. As I mentioned, we have also started to open our sales channels directly to professionals and nursing students. We are profitable. We have no interest-bearing debt. We have a strong cash balance, which did surge a good bit in Q1 to $83.7 million. That's up $12.6 million over the prior quarter, so good free cash flows and cash flows during the quarter. We are solely focused on health care, more specifically the health care workforce. That's an important number. especially given the trends I mentioned at the opening of this call. There are 12.3 million healthcare professionals and nursing students, which we define as our total addressable market. And we hope over time they'll engage with us through all three of our major primary application suites and all of our secondary applications as well. And we want them all, we want to think of all 12.3 of them, 12.3 million of them initially as members of our ecology, of our ecosystem. And we're making good headwinds towards making it a network effect or an ecology through the A-Stream platform. Well, I'd like to turn over to Scotty Roberts to take a little deeper dive into the numbers because I just hit the top couple. Thank you. Go ahead, Scotty.
spk06: All right. Thanks, Bobby, and good morning. So I'll jump right in and go over the financial highlights for the first quarter. And unless otherwise noted, the comparisons will be against the same period of last year. I'm pleased to share that we continue to deliver solid performance for the first quarter, growing both top line and adjusted EBITDA. Revenues for the quarter were $72.8 million, up 6%. Operating income was $5.7 million, up 97%. Net income was $5.2 million, up 99%. Earnings per share was $0.17 per share, up from $0.09 per share. And adjusted EBITDA was $17.1 million and was up 24%. Revenues increased by $3.8 million, or 6%, coming in at $72.8 million compared to $68.9 million in last year's first quarter. Revenues from our subscription products accounted for 96% of total revenues and were $70.2 million, increasing by 6%. Subscription revenues, as we've defined them for some time, predominantly include SaaS solutions, but also software license and maintenance fees. Software licenses are associated with legacy products such as our ANSOFT scheduling solution and are occasionally sold to existing customers. I'm calling this to your attention here because one-time license revenues were approximately 0.8 million in the first quarter, and they increased by half a million over the prior year. In fact, the 0.8 million of revenue in the quarter came exclusively from one ANSOFT sale. We do not expect one-time license sales to continue at this level, and I want to remind you that the $0.8 million of first quarter license sales should not be modeled to repeat in upcoming quarters. Additionally, our professional service revenues declined by $0.4 million, or 13%. In the last quarter, I discussed two products that are experiencing declines in revenues, so I want to give a quick update on those. The first are renewals of the ANSAW scheduling products, and the second is our quality manager solution. During the first quarter, these products collectively declined by 0.6 million, or 13%. On the positive side, our initiative to sell directly to professionals through our commerce channels delivered over half a million of revenue in the quarter. Our remaining performance obligations were 514 million, as of the end of the quarter, compared to $504 million for the same period of last year, and we expect approximately 44% of the revenue backlog to be converted over the next 12 months. The gross margin was 66.2% compared to 65.4% last year. This improvement is primarily due to the growth in revenues, and from a cost perspective, our staffing costs were down due to last year's reorganization efforts, while royalties, hosting, and software grew over the prior year and more than offset the labor cost reductions. As for operating expenses, we were able to maintain operating expenses excluding cost of revenues to a 1% increase. And most of this increase year over year was from depreciation and amortization, which was up 4%, and product development expenses were up 3%. Our G&A and sales and marketing expenses were down 6% and less than 1% respectively. Adjusted EBITDA was $17.1 million, which was up 24%. And adjusted EBITDA margin improved to 23.4% compared to 19.9% last year. As a reminder, last year's adjusted EBITDA was negatively impacted by $1 million of severance charges associated with the reorganization under our single platform strategy. Now let's go over the balance sheet metrics. We ended the quarter with cash and investment balances of 83.7 million compared to 71.1 million last quarter. During the quarter, we deployed 7.8 million for capital expenditures and paid 0.8 million to shareholders through our dividend program. For receivables management, Overall, it was a strong quarter of collections, which led to day sales outstanding of 46 days compared to 51 days last year. DSO has improved. Bad debt charges were not material. And generally speaking, the payment timeliness from our customer base remains fairly stable. Now switching to cash flows. Our cash flows from operations were up slightly over the prior year, coming in at $20.9 million, and free cash flows improved by $1.1 million, or 9%. With a strong balance sheet containing over 83 million of cash and no debt, we are in a good position to strategically deploy our available capital in a variety of ways, including M&A, dividends, and share repurchases. Yesterday, our board of directors declared a quarterly cash dividend of 2.8 cents per share to be paid in May. Our share repurchase program expired on March 31st, and there were no shares repurchased during the quarter. For this program, we repurchased $8.9 million out of the $10 million authorization. Now, as for guidance, we are reaffirming the financial expectations that were previously announced in February. We expect consolidated revenues to range between $292 and $296 million. We expect adjusted EBITDA to range between $64.5 and $67.5 million, and for capital expenditures to range between $28 and $30 million. This guidance does not include assumptions for any acquisitions that we may complete during the year. That wraps up my comments for this quarter's call. Thanks for your time this morning, and I'll now turn the call back over to Bobby.
spk09: Thank you, Scotty. I'm going to highlight a few of the areas where we saw some success in each of our three primary application suites and talk a little bit about some advances in our core plan technology we call HSTREAM as well. So our Healthstream Learning Center is the application, it's kind of the flagship product of our learning application set, and it continues to be strong in the market. But importantly, when the eight Healthstream Learning Center customers are up for renewal, we frequently see customers purchase multiple new solutions along with it when they renew. And this is kind of an example of expanding wallet shares, kind of a way to think about that. And one of our Academic Medical Center customers, use their renewal of the HealthStream Learning Center as an opportunity to evaluate how HealthStream might help them serve their entire clinical workforce. And this may be an example of the tailwind I mentioned earlier. The customer already purchased various HealthStream solutions for different subsets of their population, and when it came time to renew, they concluded that by pairing that with a renewal with a purchase of HealthStream competency suite. And, you know, that would benefit their entire clinical workforce, adding on the competency suite to the learning center. The competency suite is a comprehensive and cohesive bundle of applications and content used to develop the clinical staff. And in this case, they added that kind of that entire bundle. The customer also added our nurse residency program, which onboard newly graduated nurses, which is kind of an important kind of continuum of service from some of the work we're doing now in nursing schools. And so we saw them add the nurse residency program to the account as well. So the net result was the ARR, the recurring revenue for that customer, grew by 31%, or approximately $100,000 in the first quarter, making this a good example of expanding wallet share and kind of cross-selling products, in this case, adding on clinical competency bundles and the nurse residency program upon renewal of their base learning center contract. With our SaaS scheduling solution, Shifting Gears now, known as Shift Wizard, is a best-in-class solution of its kind, and we think it will only become more valuable to customers as it begins to integrate with other applications through our H-Stream technology platform. In the first quarter, revenues from Shift Wizard grew 26% over the prior year quarter as customers continued to report high customer satisfaction with the Shift Wizard applications. We contracted several new customers during the quarter, which we're excited about. Welcome Samaritan Medical Center, Bay State Health, and Hutchison Regional Medical Center, all new customers for Shift Wizard. We're excited to add you to our customer list. Our credentialing solutions also enjoyed a successful start to the year, both in terms of competitive takeouts and conversions from our legacy solutions. And you're going to see an increased focus by our sales team on these conversions this year. We think it's really time now, as we tell our customers at the start of the year, time to migrate. So if you're on our older legacy platforms of Healthline and Morrissey, you'll be hearing from Healthstream that we think that credential stream is right for you and it's time to get under the migration process. So this best-in-class solution for enrolled and privileged physicians is really just in a market-leading position, we believe. One thing you may not know about credential streaming, one of its differentiating characteristics is we believe it's the first credentialing solution that really engages with the physician in the credentialing process. We think of it as much more user-centered software, and we think that's a good thing. We see increasing traffic by physicians logging in and taking control of the credentialing process individually and professionally. And so we're proud that our patient suite is kind of physician-centered in many ways, and we think that's consistent with being the people platform of healthcare. We want to make that as pain-free a process as possible for physicians, and we laser focus on the net promoter score from physicians on that particular application. So you may not have known that one of our twists is that our credentialing system has a lot of tools that are easy to use by the physicians themselves to take control of the process. In the first quarter, we contracted 33,000 new subscribers for Credential Stream, which is an exciting add. And we've now exceeded over 1 million subscribers on the Credential Stream application suite, which is really exciting. And we welcome new customers like Arkansas Blue Cross Blue Shield, which is really exciting because it's a slightly different kind of customer profile than our acute care hospitals. Tufts Medical Center, Dartmouth Health, and Littleton Regional Healthcare all added the Credential Stream application suite. to their processes, and we're excited to welcome them as customers. In terms of our platform solutions, the momentum we're seeing with regard to customers' use and adoption of our APIs is paving the way for an exciting future for the company. As a reminder, we launched the HStream developer portal in the fourth quarter of 2022, so it's fairly new. I think of this developer portal as a window into the actual platform. So we've talked now about the three application suites, But the platform that we call HStream is driven by a growing library of APIs that we make available under license to our customers. And some of them get access based on the fees they've already paid. Like if you use the HealthStream Learning Center, you get access to learning APIs. But over time, we also think these APIs and their capabilities and data sets that are in the platform will themselves become monetizable assets. So we're excited about that. And the developer portal kind of is a sign of life or a sign that the platform strategy is working, we saw a doubling of different measures of utilization of these platform-level capabilities. So the portal provides access to modern, scalable, secure architecture with a growing collection of shared services, platform-level applications, and APIs to connect to and among all of these different components. At the end of the first quarter of 2024, 104 healthcare organizations have chosen to open an account on the developer portal which is kind of how you get access to these APIs. And collectively, 237 of their developers have account-level access to a growing library of APIs, most of them currently in the learning area, to then integrate our technologies into their broader technology environment, for example, into their intranets and other applications they may build. And for example, in the first quarter, Stanford Healthcare built an internal app that provides easy access to epic course completions and so here's an example using the developer portal the apis by stanford health who have licensed access to these apis because they're a customer of the broader you know hstream platform and they are incorporating those into this new app that helps them deliver access to epic course completion so it's really exciting and there are plenty of other exciting examples a new england life filter app conveniently retrieve course and assignment progress and they're also using the apis in the developer portal so as these apis get more and more utilized we still get more threaded in to the broader 10 platforms of our customers so we think that demonstrates the value of our platform strategies uh increasingly and hopefully provides more value and utility to our customers And we think, again, as the platform expands, there'll be more and more capabilities in the platform, more reasons to use it, and more interoperable. And the long-range vision, of course, monetizing these capabilities directly is also an exciting possibility. So I think, you know, as I think about concluding, I'd say if you're interested in a profitable recurring revenue, SAS, and increasingly a PAS, the Platform as a Service Healthcare Technology Company, That for 2024, we expect to deliver steady growth, kind of down the middle of the fairway of our guidance, in fact. And we've determined to share some of our gains directly with shareholders in the form of a dividend, one which we increased last quarter. Maybe health is a good company and a good stock for you if you're a new investor. If you're a shareholder, we welcome you to participate in and know, remind you that our annual shareholder meeting is scheduled to take place virtually on Thursday, May 30th at 2 p.m. And notifications of the meeting and access to the proxy statement, 10K, and shelter letter were sent out on April 15th. So if you're a shelter, we encourage you to vote your shares and participate in the future of our company. I'll now turn it back over to the operator to begin the questions.
spk03: Thank you, sir. The question and answer session will begin at this time. If you're using a speakerphone, please pick up the handset before pressing any numbers. Should you have a question, please press star 11 on your push button telephone. If you wish to withdraw your question, please press star 11 again. Your questions will be taken in the order they are received. Please stand by for your first question. And our first question comes from Matt Hewitt with Craig Hallam. Your line is open.
spk04: Good morning and congratulations on the strong start to the year. Maybe the first question, it appears that the employment situation at your customers' hospitals, healthcare systems is improving since last year. And as that occurs, how are you seeing that change the purchasing decisions? I think you spoke a little bit about how you're seeing your customers are paying more attention to their workforce today than maybe they did pre-pandemic. But are you seeing them even starting to implement health stream applications and solutions right at the beginning with the onboarding process? And are you seeing, I guess, a greater wallet share with those customers starting on day one versus upon renewals and downstream from that initial hire?
spk09: I don't have to think through all that. There's a lot of different trends, purchasing, and patterns. I think one of them is we've done a little better job of bundling some of our products into suites now that can result in a little higher order value. And I mentioned that competency suite sale as an add-on earlier. The competency suite is kind of an aggregation of two or three products that used to be sold individually, and now they're viewed as a more comprehensive tool set to develop the competencies of staff. And so, you know, we're learning to position things in a little better way that's more consistent with the tailwinds I mentioned. I definitely think the pandemic created a greater, as I mentioned earlier, a greater awareness of the need to invest directly in your workforce and make their lives better and help them do their jobs better and skill them up for new job opportunities inside the organization. So I think there is an earlier increase in awareness in the need for investing in workforce development. You can't just outsource your workforce. I think people are now willing to invest hopefully a little more in the workforce and make that more of a priority discussion in the C-suite. And then as far as moving upstream, I think, yeah, on the call we demonstrated our strategies for moving upstream are getting to the workforce before they become the workforce. So the nursing school market, it's very early, but we're excited about what that can mean for us as we can catch people earlier in their career. In fact, I think we did release a white paper, a study, a press release not too long ago, that talked about the workforce's increasing need for mobility and to find and develop and retain the nurses and that they were willing to take jobs at the places where they had kind of interned or done their rotations. And hospitals need more help in recruiting those precepted students and making them full-time employees. And we think Healthstream might be in a good position to help with that problem over time. Again, it's really early and early research, but a lot of the students doing clinical rotations before the nurses at hospitals we think are great hiring candidates down the road. another way we're going upstream, as you mentioned. So, yes, in all those ways, I just think a little better attitude about investing and a little better bundling strategies for us in our deal pipeline.
spk04: That's really helpful. Thank you. And then maybe a separate question regarding the opioid course. Obviously, you know, it's nice to have a tailwind like that, a government-mandated tailwind. How quickly are hospitals expected to implement That type of a course. And what could that mean? Is it a driver for this year? Could it add 1% or 2% to revenues this year? Just trying to think of how to kind of factor that in.
spk09: A couple of things here, and you pointed out rightly. This is kind of a unique opportunity, so we don't want to get, I mean, it's exciting, right? We did a half a million in the quarter, so if we can find a way to keep that rate up, and remember, that's direct to professional sales, so we don't necessarily see any institutional purchasing of that course, or certainly not much, but the direct opportunity to get to a physician who has a renewing license where this is a requirement drove a half a million in sales in the quarter. So, yeah, I think, you know, if we can keep it up, it's going to be a nice small contributor, but We also want to be careful to not over-extrapolate our capabilities of selling direct to individuals. We think it's kind of a good fortune that requirement and the curriculum we already had and our ability to market now these channels and our new e-commerce tools set us up to do well in the first quarter. But it is kind of a one-time mandate. So we don't, again, at some point in the next 24 months, everyone will have met the requirement or not. And it was a unique set of circumstances, so we don't want to over-excite about that. So, you know, we just want to – that's why I keep saying the middle of the fairway, middle of the fairway. And we also had an anomalous bit of revenue in the one-time license, which we don't – obviously, we don't focus on selling the enterprise license like we mentioned on ANSOS. But we did – you know, we're not going to – a customer wants to expand their use of ANSOS, we're going to take that business and And we don't want to over-engineer the forecast based on that one-time license, which I think Scotty called out at about, you know, I think it's $700,000 or $800,000. And so we middle of the fairway, middle of the fairway is what we keep saying.
spk04: Got it. All right. Thank you very much.
spk03: Thank you. Our next question comes from Jared Hayes with William Blair and Company. Your line is open.
spk07: Yeah, good morning. Thanks, guys, for taking the questions. This is Jared on for Ryan Daniels. Bobby, you talked a little bit, I think, in the credentialing segment about a win with a payer. And I'm curious, I think that's relatively new. So just be curious to hear a little bit more as to how we should think about the opportunity with payer customers. And then specifically, it sounded like that was a Blues plan. So I'm wondering if you see an opportunity here to sort of further penetrate the network of Blues plans nationwide.
spk09: Well, okay, so first we're excited you picked up on that. And yes, it's a new type of customer for us. We think that our credential stream application and the way we built it might give unique benefits to that market segment over time, the way that it's been engineered to work and create data mobility. Sometimes health plans are owned by health systems and that might create some interoperability benefits that we see potentially in the future. So yes, it's an example of one. But it's kind of exciting new development if you're in the sales team in that area. And we do think we have a unique set of capabilities in the app that could be beneficial to health plans. That said, health plans are hard to sell to. It's new for us. We got a lot of work cut out for us. But if you think in terms of two to three years, I'd love to see that become a thing for us where we can have a presence in that segment as well. So, again, hopefully the way we built the application and its interoperability and potential data mobility will provide some benefits to health plans, particularly when they're owned by hospitals and health systems. And, yes, that was a blues, but we don't claim to have any particular expertise in selling the blues. It's new for us, again, and required some new modeling, new selling approach. You know, we'll see where it goes. I think we got a shot at making that an opportunity that repeats more than once.
spk07: Got it. Yeah, that makes sense and look forward to hearing more over the coming years. Maybe another follow-up just from the prepared remarks. Bobby, I think you talked a little bit about enterprise purchasing collaboratives. And I know it sounds like it's not a material part of the business today, but I was hoping, number one, if you could maybe just contextualize sort of what portion of bookings or ARR growth comes through a collaborative purchasing today and maybe where you expect that to get to over the next few years. And then it also sounded like that's evolving with some additional capabilities. So we'd love to just hear a little bit more about that as well.
spk09: Yeah, so the collaborative purchasing process for enterprises kind of benefits them the most. It's a way for them to organize and orchestrate their purchasing of certain of our offerings. So if they've got, you know, a dozen different things they're looking at, it's a really organized kind of 90-day way for them to see all the products in the bundle, organize demand for it across multiple, say if they have 30 or 40 hospitals and they want to figure out how much they need at each facility based on the CNOs at those facilities, So it's an engagement model we've used for a long time. It used to historically be very manual, kind of led by people and essentially our consultative sales process. But we've formalized that into digital tools that gives the organization visibility in how demand is growing and each, you know, as orders are kind of indicated on a product, it kind of aggregates the orders. So at the enterprise level, they can see that. At the end, there's a discounting model that elipses them. get a discount based on the volume commitment levels as they grow. So it almost gamifies the purchasing process. And it's budget aligned. So they can do the whole process aligned with their budget purchasing cycle. So product collaboration is, again, not widely deployed, but we've increasingly built digital tools to facilitate it. So, for example, now the pricing models are connected directly to our price book capabilities and our sales tool sets that we have. So now the collaborative software will present As you commit to higher volumes in the purchase process, you can see the discounts occurring automatically because the way it's connected digitally to the price booking mechanism that we hold in Salesforce. So, you know, I hope someday that we can extend these capabilities more broadly and they'll continue to get better and better and easier to use and more budget aligned and more products in the cloud. But, you know, it's been a part of our purchase process for years. It does several million in orders. in aggregate orders, but a small portion of overall orders are achieved through the collaborative process. But we love it because it's enterprise-level purchasing on an increasingly automated tool set powered by the HStream platform. And at the other end of that spectrum, you mentioned new capabilities. In the middle, we believe that there are kind of untapped budgets at the departmental level because sometimes they orchestrate at the enterprise level. But our commerce tools are also now being geared for, and we hope to launch this year, the ability for kind of managers. Let's say I have a department budget of $3,000 that I can spend on education for my department. We typically, those are areas we didn't even sell. Our sales team would go to the enterprise level. And so now we have these commerce tools that may allow kind of at the department level people to shop and buy things. So we'll see where that goes this year. That's currently kind of at zero. The tools have been built. We've seen them. and demonstrated them, but we haven't really released them. So we're excited about that. And then the far end of the spectrum is direct to professional commerce. We talked about the DEA-MATE course. We can now kind of open little mini learning stores, if you will, like a single course available to doctors. We could say, oh, you know, check out this course that meets this federal reg. They click on it and they can buy that one course directly as a professional in our network wants to have an HSTREAM ID on the platform. We saw half a million in sales, and that revenue was recognized immediately in the quarter, which is kind of fun. Now, consumer revenue is a tiny, tiny fraction of our overall company, direct to professional. But I just think, I call it money while you sleep. It might be fun to fill a lot of gaps each quarter with individuals buying to their individual development needs with their own credit card. And again, we didn't do a lot of that in our past. So it's just, it's fun to think that millions of customers may ultimately not just be customers through the organization, the B2B purchasing, but maybe someday a lot of them will buy services directly. And we do have an example of that now with this DEA-made course. So, again, we don't want to over-engineer these things or get too excited about them. They're all good, promising signs for the future. The enterprise-level purchasing, we're not doing department-level purchasing, but we have new tools for it. Direct professional commerce is nascent. but kind of fun and exciting to point out. And more than anything, it's the interoperability of all these things that we're excited about as the platform features and functions grow, expand, and add these kind of capabilities we're talking about. Some of them let us have better commerce. Some of them let customers move a credential earned in one to a location in another application and follow people around individually with their data. So emerging capabilities give us excitement for the future.
spk05: Thank you for the question.
spk09: I guess I had such a long answer I scared off the Q&A queue, but we're still here if you have more questions.
spk03: Thank you. Our next question comes from Richard Close with Canaccord Genuity. Your line is open.
spk01: Good morning. Thanks for the questions and congratulations. Maybe a follow-up to Matt's first question. A good example there with the 31% increase in ARR with the uh, academic medical center. I'm just curious when you look at your book of business for the SAS offerings, like what percentage of customers come up to come up for renewal on an annual basis? And then maybe put in that 31% into perspective is, you know, are you seeing, uh, an acceleration or I guess growth in that, uh, you know, percentage increase in ARR, you know, versus, you know, one to two years ago, maybe any insight or perspectives on that would be great.
spk09: I think overall growth rate would be much higher if that was more prevalent. You know, I think we obviously gave an exception here, which is one that bundled. But, you know, our sales team, our account managers are focused on this kind of account expansion. We do see, you know, give and take. So if they had four products up for renewal, they renewed three of them. Maybe they used one less and they added two new ones. So that's what account managers do. We have about 60 account managers that focus on this cross-sell upsell. And there are puts and calls to the whole process. Again, if they have four products, renew three. They say, well, we didn't use that one as much, but our account managers, if they're really good, they do what this group did here, and they add two or three new products. The other thing that's shifting, Richard, and so I would say we give the best example. We don't want to over-engineer. It's not happening on every renewal yet. But it's, of course, our model and our objective. That's what we want to do. The other thing that's happening is, and so a bit is that we're doing a better job bundling things. Like if you take these combis as an example, so that the initial order value can be a little greater. And that's resulted in a little delay in the Q1 pipeline, but more bigger deals in the pipeline than we've ever seen. And so, for example, in the comps, there's a lot of content that we used to sell separately. The checklist tool is in there. Jane is in there. And so there's a way now that instead of a CNO making an argument upstream four times to buy four separate products, they can evaluate making a real investment in their workforce to buy the suite. And so that's some repositioning that you can in Q1. And the effect is more bigger deals in the pipeline than we've seen, but also in Q1 a little delay purchasing in some areas as we've made that shift. So I'm excited about kind of hopefully where Q2 takes us. through this bundling strategy. And hopefully that grows that ARR that you're talking about. But, you know, obviously overall, with our overall growth rate, we're not seeing every renewal come up and grow by 31%. That's a case study that we want to emulate more than it is an example of a broad occurrence.
spk01: Okay, that's helpful. And then maybe on the excuse me, decline in renewals and stuff, I understand. Is there anything to be concerned with on the quality manager? That seems to be something new. Just want to make sure I understand that.
spk09: Yeah, the quality manager was from an acquisition years ago. It's focused on the skilled nursing market. And, you know, that market is under a lot of stress financially and kind of reengineering and working on defining their space better, I think. So, Slow purchasing there, tighter budgets, the quality manager, again, it's not overall a huge part of our business, but it's enough where we don't like to see declines. And so we'll fight to continue to position that product, but it's predominantly sold to the skilled nursing market. We're building a version that could be sold to hospitals, but that's a more competitive space. So I think just in general, we have dozens of products. This is one of the smaller ones that may be facing kind of a market level challenge. And, you know, we'll do what we can to fight through it, but it is, we did note it as a decline along with, with Ansos. Not as big, Ansos, so not as big a risk.
spk01: Okay. That's helpful. And then, you know, I'd welcome your perspectives. You just talked about the pipeline, some bigger deals in there, maybe a little bit longer to, get across the finish line, but it doesn't sound like you're too concerned with that. I'm just curious, with respect to change healthcare and everything that's going on with that over the last several months, have you seen any impact in you know, your book of business in terms of, you know, potential new business or renewals, you know, people pulling back just, you know, based on everything that's going on with the change healthcare. I'm just curious.
spk09: No, I don't know, Richard, if I've been able to relate the change healthcare to any purchase patterns. Again, we saw a little lighter purchase patterns in Q1 than we wanted. I think that's due to some of our rebundling strategies You know, we had a great fourth quarter, so we pulled a bunch of deals in the fourth quarter. We're rebuilding for the second quarter, so we've got some work to do there. But I haven't been able to relate that to any macro trends or something like the change healthcare kind of challenge that occurred for the whole industry. You know, I see a little bit more duress in like the skilled nursing market. I've A few more acute care systems are known in the public to be under financial stress. But also, I think the tailwind, so that's the headwinds, are kind of some macro condition things for customers. But the opposite, in fact, is the workforce trends that we're seeing, you know, the interest in the workforce. So the bundling and the bigger deals and the more bigger deals in the pipeline is exciting, but hopefully it doesn't take too much longer to close them. But I think that is maybe a more direct result of the interest in both how we're bundling our products and the interest in investing in the workforce, which is a direct shift, I think, in their attitude about the value of retention and developing versus maybe pre-COVID. And I think they got so tired of staffing nurses filling a lot of their positions, they want to develop their own employees now. So I hope that plays out over the next few years is what we're hoping.
spk01: Okay, that's helpful and good to hear. And then maybe, Scotty, with respect to sales and marketing, as we think about the second quarter through the rest of the year, is there anything to keep in mind in terms of, you know, maybe seasonality or, you know, events or anything like that? with respect to the remaining quarters?
spk06: Yeah, I think Richard and marketing in particular, we've set an expectation when we plan our budget to attend more in-person events. We actually had one in the first quarter that was our own customer conference for credentialing customers called Thrive. That was the name of that event. We also plan to continue to do more events throughout the course of the year. I think some of those tend to be scattered across the quarters, but I don't know if there's a particular quarter where we'd see kind of an outsized presence necessarily that would impact the P&L materially, but there should be some continuation of events we expect you know hiring you know you can expect us to continue to hire sales positions as needed so that should feather in across the year but again probably not going to impact any particular quarter significantly okay that's helpful thank you very much hey Richard I like to just reinforce a couple of things you know the quarter was obviously strong but
spk09: There were a couple one-time comparators that we just need to make sure. That's why we keep saying middle of the fairway. You know, we don't want to over-engineer the result. The ANSOS one-time license was a one-time benefit. And also, on a year-over-year basis, the restructuring last year, which we did, it's kind of also an expense change that, you know, we got some benefit from, but we didn't do another reorg. And so we just want to be excited about the quarter, and it's the total result. We also want to be, you know, and we point out some of the things that could impact our future in a positive way. But right now, you know, we're sticking to our range and kind of pushing people to think about the middle of the range is where we think we are.
spk01: Okay, that's very helpful. For the full year and for each quarter.
spk09: Yeah, just kind of a really strong, exceptional first quarter, even from a free cash flow standpoint. You know, typically, for example, another trend would be in the second quarter, our free cash flows are not as strong. I think Scott can comment on maybe more, but that's a quarter where we pay out a lot more royalties and commissions are, I think, usually higher in the Q2 and Q4. So maybe Scott can comment on that. Yeah, sure. Because we accept Q1 on free cash flow as well.
spk06: Yeah, I think if you look back at last year in particular and probably look at several years of trend, you'll see that Q1 and Q3 are typically our strongest free cash flow quarters. with Q2 and Q4 tending to tail off. I think even last year's second quarter was flat to negative. And so another consideration is just timing of federal income tax payments. State income tax payments tend to not be on a quarterly recurring basis, so you should expect some of that to pop in the second quarter as well, a similar trend that we saw last year.
spk01: Okay. Thank you very much. I appreciate it.
spk00: Thank you.
spk03: Thank you. Our next question comes from Constantine Davids with Citizens JMP. Your line is open.
spk08: Hi, good morning. I apologize if I missed this, but reporting a consolidated ARR has been something you talked about previously in terms of a new way for us to understand the business better with an expectation that we'd get something around mid-year. Can you just provide us with your latest thoughts there and if there might be you know, other potential KPIs you're also considering?
spk09: Yeah, I mean, we're trying to chase down everything from return on invested capital, and when we looked at it, there's 30 ways to talk about it. We're looking at internally, we use ARR to account management level at the account level, but not the company level, and so figuring out how to calculate and reliably do it. We would probably have to, you know, commit to a metric internally for a few quarters and see how it plays out before we release it publicly, so... You know, we're probably now looking at Q3 at the earliest for new metrics. And so, no, Constantine, nothing new to report today, but we're working on it, you know, because we retired a metric and we're working on finding other new metrics. Scotty, do you want to comment any more on the things we're looking at, at least to give a hint about it? But I do think we're several quarters away because, again, we would have kind of more adopted internally, run it for a few quarters, and then figure out how to talk about it, get our definitions straight that we would want to use, you know, Of course, we have our own internal definition of free cash flow and things that we monitor, but nothing planned to release right now. Scotty, any more details?
spk06: Yeah, I think ARR is one that we're – obviously, we've looked at and used internally, as Bobby mentioned, on a more an account-by-account basis. Yeah. You know, Constantine, you know, some other retention metrics, you know, we're considering, you know, whether or not those are worth sharing publicly. We're, you know, obviously been focused on those internally as well, but just trying to get to the point where we want to share those publicly. So, you know, net retention in particular is a possible metric as well.
spk08: Great. That's helpful. Bobby, the 104 organizations you called out hitting the portal, I just want to be clear, they're not paying at all for that kind of access. So I guess, you know, what is the expectation on maybe starting to monetize that? And what do you need to do to, you know, commercialize that or support it? And how, you know, is that sort of a later this year event? Is it a next year event? Just wondering how to think about that opportunity.
spk09: Yeah, sure, so a couple things. First of all, effectively they are paying for it, and here's how. When you buy an application like the HealthStream Learning Center, you also buy a subscription to HStream for Learning. HStream for Learning is a license in your agreement that gives you access to some of the APIs that comes with your right, and you do pay for that HStream for Learning subscription. So those two subscriptions together are what give you the access to several of the APIs as a customer. So most of those 104, that are utilizing the rights they've gained by paying for the H-Stream for Learning license, for example. That said, we have had some examples, commercial success, of individually licensing some of the data sets, and we have some proposals out to other customers to license the functionality of the platform directly. And I think we've given some examples, but as we get more and more of our data sets, like our privilege library, our regulatory compliance library that are content libraries, directly accessing them through the platform for license fee, for example, or we've also given the example of looking up a license validity. We currently give our customers access to that function in our applications, but we have an example of a third party licensing that function to check a license validity on an API basis only. And we had a health system that didn't buy an application from us. They just paid for checking licenses. And so we have some limited examples of directly monetizing both the data and the functionality of the platform. But mostly, the 104 people and 200 nearly developers in the portal are there by the right they gained by paying for their H-Train for Learning license. And they're utilizing those APIs to thread our technology more into their technical environment, like their nets, for example. So it is paid for in a way. In fact, it's part of the, if you say, you know, what's the value proposition of HStream, the platform? Customers would say, oh, I get access to developer portal and I get to use some of these APIs. A lot of them are being engineered in a way where they could be sold to non-customers directly to APIs. And that will be the learning journey. And I hope to have examples of monetizing directly in that way in each category of data and APIs by the end of the year.
spk08: Got it. Thanks. If I could just squeeze one last one in here. Obviously, you guys are in a really good cash position, no debt. In terms of just M&A opportunities, I'm just curious, you know, are you pretty committed, at least in the near term, to the three application suites you currently have or You know, is there a possibility you even start to sort of expand upon that prior to having the unified platform sort of fully realized?
spk09: Yeah, I think, Kostin, we are already focused on expanding the kind of these three areas, the three application suites, meaning within their own context. So, you know, if we find something that bolsters our learning capability, that would be something to look at, our credentialing, our scheduling, but not adding a fourth dimension. The only fourth dimension we have is the platform itself. We call it HStream. So we want to get all four of those, the three application suites and the HStream platform, working together really well. And I think this is the year where we want all these ways to demonstrate that interoperability. We just talked about one, which is, you know, when you license the learning center and you get a licensed HStream for learning, you get access to the APIs. That's a good example of adding value to our network. And so our M&A strategy is, adding to those areas that they already exist more than creating new areas of business and focused on the interoperability is kind of a key word for this year and also focused on the migration of legacy customers so if you're on a legacy credentialing application that we acquired to say the credentialing the modern application we've been building and selling now with over 750 accounts on it so you'll see this year is more of us on on conversions from legacy to existing, which unfortunately don't have a lot of revenue growth. I mean, they do grow revenue a little bit when we convert, but what they really do is get people solidly on the new application suite. So that's a focus this year. And then our M&A strategy specifically asked about is to bolster existing areas. So incremental add-ons to existing areas, more than expanding the model into new areas. Now, if we get it all working in the next 18 months, then maybe adding a fourth operational dimension to the network would be exciting. But right now, M&A would be focused on areas that strengthen the current lines of business.
spk05: Thanks, Bobby. Thank you.
spk03: Our next question comes from Vincent Colicchio with Barrington Research. Your line is open.
spk10: Yes, Bobby. Another strong quarter for ShipWizard. You added a few new clients. Curious if they were mostly, I assume they're mostly mid-market clients, and if that's correct, when may you be prepared to move up to larger enterprise clients?
spk09: Well, we're working on that. I think you're right. I mean, generally, that product is great. We have some good examples of big systems that are using it, but I think, in general, the successes are coming in the mid-market right now, and that's the focus of our sales team. So we continue to try to expand its capability and make it more relevant. We have ambition to integrate properties like NurseGrid, the app, to the shift wizard application, which would extend its functionality. And so I think right now, though, for the next six to nine months, maybe even for the full year, the remainder of this year, our focus is that middle market.
spk10: And one last one. Anything in the competitive market worth calling out since last quarter?
spk09: No, I don't think anything particularly. I mean, everyone, including Healthstream, is working on their AI strategies. So we see different approaches to that. With our Jane technology, it continues to evolve. We're excited. We have some things in the pipeline to refresh our learning technology stack that we're really excited about for the second half of this year. So we're working on our competitive positioning there and our thought leadership and our application leadership in that area, which You know, it hasn't been revitalized in quite some time, so that's a little sneak peek that we've got some innovation coming in our learning business that we hope to catch the competitors with. But in general, it is a very competitive landscape with lots of wooded startups and big established companies as well, and we're just fighting for our piece of that or more than our fair share.
spk05: Thanks, Bubby.
spk03: Thank you. Our next question comes from Stephanie Davis with Barclays. Your line is open.
spk11: Hey, guys. Thank you for taking my question. I'll try to keep it brief just given the length of the call. But you've been talking a little bit more about sunsetting activity and being more proactive on that as a pair of remarks. Is there first any way to tease out what your growth would look like excluding the sunset impacts and get a cleaner number for your go forward? And as a follow-up, could you talk to us more about maybe the pushback you're getting and any sort of updates on the timeline for the process?
spk09: Yeah, I think we've determined early this year, like in January, that we need to focus in some areas like where we have legacy platforms, so credentialing and scheduling, and both have legacy platforms, that the message to our existing customers is twofold. We're not sunsetting, so that word we need to tone a little bit because we're still, of course, supporting and releasing enhances to some of those legacy platforms and communicating frequently with customers how to better optimize their use. So you did see, for example, expansion of ANSOS. We actually had two big wins at ANSOS. We were able to convert another big contract into a more healthy model financially, and then we had the big ANSOS license expansion. We are supporting those. We're just not actively outselling. The customer wants to expand useful sell, but we're not sunsetting. We are changing the tone of our message, though. Beginning in January at that conference that we mentioned earlier, we said now is the year to migrate to the SaaS application stacks. And so that's different than stay comfortably where you are and wait for migration. Now we're actively promoting to customers that now is the year to migrate. And so the tone of the sales organization, the tone of Healthstream is that. And as I mentioned, that does tamp down growth a little bit because you're kind of switching from one dollar set to another. There is a bit of an uplift in the annual recurring revenue when you go from the maintenance models that they're under. So it's positive, but it's not nearly the same as, say, acquiring a wholly new customer. So, yeah, that does have a little bit of a dampening effect on to have that as a focus as a bit of a dampening effect on the top line. But look, it's the healthiest thing to do and the right thing to do is to is to begin a more aggressive migration strategy from the older. But we're not doing that by actually sunsetting. We're doing that by encouraging and stating and giving examples of where migrations are successful. We're just better at it. We're better at the tools. So you talk about barriers. We have better data migration tool sets. We have better methodologies. We've learned a lot from the early migrations. And overall, our teams are doing a great job. And so we're communicating. We have more confidence we could handle more migrations now, too, because of all that I just mentioned. So great question. It makes top-line growth look a little less stellar to make that a focus, but it is absolutely the right thing to do for a 24-month horizon. And, again, we're better equipped technologically to facilitate those, and the marketing message has changed. So thanks for the question, and I hope I got the answer.
spk11: Thank you.
spk03: Thank you. There are no further questions at this time. I'd like to turn the call back over to Bobby Frist for any closing remarks.
spk09: Thank you, everyone, and congrats to our employees. A lot of hard work going on to make all this happen. Look forward to reporting the next earnings call to everyone, and we'll see you on the next call. Thanks, everybody.
spk03: Thank you for your participation. This does conclude the program, and you may now disconnect. Everyone, have a great day.
Disclaimer